Intellia Therapeutics NTLA
NASDAQ NTLA
$12.26 +0.14 (+1.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Change in Accured Expenses (2015 - 2026)

Updated

Intellia Therapeutics (NTLA) reported Change in Accured Expenses of $6.36 million for Q2 2026, up 663.9% from $832,000 a year earlier.

Analysis

Intellia Therapeutics (NTLA) Change in Accured Expenses (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Intellia Therapeutics' Change in Accured Expenses came in at $2.72 million; for FY2025, it came in at -$5.27 million.

  • By year, Change in Accured Expenses came in at -$10.38 million in FY2024, $6.02 million in FY2023 (-62.2%), $15.92 million in FY2022 (-7.7%) and $17.26 million in FY2021 (+32.5%).
  • Five-year quarterly Change in Accured Expenses spans a low of -$22.4 million in Q1 2024 and a high of $18.43 million in Q4 2021.
  • Year over year, Change in Accured Expenses gained in two of the last five quarters, with growth averaging 129.3%.
  • The high point for year-over-year Change in Accured Expenses in five years was Q2 2026 (growth of 663.9%); the low point was Q4 2022 (a decline of 83.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$11.95 million (Q1 2026), $9.03 million (Q4 2025) and -$715,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Intellia Therapeutics 1.72 Bn 1.72 Bn - 6.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.36 Mn
Mar 31, 2026 -11.95 Mn
Dec 31, 2025 9.03 Mn
Sep 30, 2025 -715,000.00
Jun 30, 2025 832,000.00
Mar 31, 2025 -14.42 Mn
Dec 31, 2024 3.95 Mn
Sep 30, 2024 6.22 Mn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -22.40 Mn
Dec 31, 2023 9.03 Mn
Sep 30, 2023 9.52 Mn
Jun 30, 2023 4.87 Mn
Mar 31, 2023 -17.39 Mn
Dec 31, 2022 3.07 Mn
Sep 30, 2022 13.57 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 -3.72 Mn
Dec 31, 2021 18.43 Mn
Sep 30, 2021 -11.31 Mn
API Access

Intellia Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NTLA&period=max&api_key=YOUR_API_KEY